Federated Hermes’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,351,900
| Closed | -$29M | – | 2053 |
|
|
2023
Q4 | $29M | Hold |
1,351,900
| – | – | 0.07% | 301 |
|
|
2023
Q3 | $27.9M | Buy |
1,351,900
+288,400
| +27% | +$5.95M | 0.07% | 291 |
|
|
2023
Q2 | $31.4M | Hold |
1,063,500
| – | – | 0.08% | 293 |
|
|
2023
Q1 | $24.5M | Buy |
1,063,500
+288,500
| +37% | +$6.65M | 0.06% | 337 |
|
|
2022
Q4 | $21.6M | Buy |
775,000
+118,407
| +18% | +$3.29M | 0.06% | 364 |
|
|
2022
Q3 | $20.2M | Sell |
656,593
-12,336
| -2% | -$379K | 0.06% | 377 |
|
|
2022
Q2 | $19.7M | Sell |
668,929
-236,316
| -26% | -$6.95M | 0.05% | 395 |
|
|
2022
Q1 | $29.1M | Buy |
905,245
+169,813
| +23% | +$5.46M | 0.07% | 355 |
|
|
2021
Q4 | $32.8M | Buy |
735,432
+396,272
| +117% | +$17.7M | 0.06% | 362 |
|
|
2021
Q3 | $17.1M | Buy |
339,160
+200,528
| +145% | +$10.1M | 0.03% | 516 |
|
|
2021
Q2 | $10.9M | Buy |
138,632
+8,672
| +7% | +$680K | 0.02% | 624 |
|
|
2021
Q1 | $7.42M | Sell |
129,960
-104,240
| -45% | -$5.95M | 0.01% | 743 |
|
|
2020
Q4 | $19.6M | Buy |
234,200
+106,005
| +83% | +$8.88M | 0.04% | 474 |
|
|
2020
Q3 | $4.59M | Sell |
128,195
-149,268
| -54% | -$5.35M | 0.01% | 745 |
|
|
2020
Q2 | $6.71M | Buy |
+277,463
| New | +$6.71M | 0.02% | 630 |
|
|
2019
Q3 | – | Sell |
-103,755
| Closed | -$2.15M | – | 2223 |
|
|
2019
Q2 | $2.15M | Buy |
103,755
+833
| +0.8% | +$17.3K | 0.01% | 1034 |
|
|
2019
Q1 | $2.39M | Buy |
+102,922
| New | +$2.39M | 0.01% | 990 |
|